CXCR2 and neoplasm: Thus, CXCR2 is considered a marker for poor prognosis in many tumor types and, in fact, CXCR2 blockade has been reported to re-educate TAMs and inhibit tumor growth in mouse models of pancreatic ductal adenocarcinoma (PDAC) [62].